The president said he would first install a “small tariff” on pharmaceutical goods before ratcheting up the rate over the ...

Pfizer's Albert Bourla told investors that major drugmakers are "ready to to roll up their sleeves" and build out more direct ...

Since becoming Vertex's top scientist in 2015, Altshuler has helped the company become an industry powerhouse. He’ll depart ...

The drugmaker shed billions of dollars in value after it told investors that widening Journavx’s approval to chronic pain ...

The investment, which the foundation says is its largest in women’s health to date, will support research in maternal health, ...